Recent studies in our laboratory has confirmed its antilithic role in experimental rat urolithiasis. A pentacyclic triterpene, lupeol was also isolated and it showed promising effect in rat models (5) . The present work aims to investigate the effect of lupeol on urinary oxalate levels and urinary marker enzymes reflecting renal injury.
MATERIALS AND METHODS
Male albino rats of Wistar strain (150-180g body weight) were acclimatized to laboratory conditions and were nourished with commercially available pelleted (Gold Mohur, Hindustan Lever Ltd., Bombay, India) rat feed. Water was given ad libitum. Experimental hyperoxaluric condition was induced by the gastric administration of 2% ammonium oxalate for 15 days. The dosage of lupeol was fixed at 25mg/kg body weight/day/rat. It was arrived at from reports where 10-50 mg/kg body weight of lupeol was administered to implanted rat urolithiatic models (6).
Experimental set-up: The animals were divided into four groups of six rats each and treated as follows: Group I:
The animals served as controls and were maintained on normal diet for 15 days. Group II:
The animals were administered 2% ammonium oxalate by gastric intubation. Group III:
The animals were administered lupeol (25mg/kg body wt/day) dissolved in olive oil for 15 days by gastric intubation. Group IV:
The animals received both 2% ammonium oxalate and lupeol as described above for 15 days. Table I represents the effect of lupeol on the urinary excretion of oxalate , creatinine, citric acid and glycosaminoglycans of control and hyperoxaluric rats .
Urinary oxalate was found to be elevated in the ammonium oxalate administered (Group II) rats (p<0.001). Supplementation of lupeol brought about a reduction in the level of urinary oxalate on the 15th day in both controls (Group III) and hyperoxaluric rats (Group IV).
The levels of creatinine and citric acid were found to be decreased in hyperoxaluric rats (Group II) and were normalized to a great extent on lupeol supplementation.
Glycosaminoglycans (GAGs) being calcium-complexing agents were found to be lowered in the urine of lithogenic rats . On administration of lupeol, their excretion was further reduced (Group IV) .
The urinary excretion of various enzymes originating in the kidney has been depicted in Table II . LDH, the major oxalate-synthesizing enzyme , was elevated in the urine of hyperoxaluric rats (p<0 .001), as was the level of inorganic pyrophosphatase (p<0.001). Lupeol administration lowered their release (Group IV) into urine considerably when compared to hyperoxaluric (Group II) rats . possibly enter the urine from other sites along the genitourinary tract (22). On lupeol administration, the lowered citric acid level was found to be considerably elevated, thus ascertaining diminished calcium oxalate crystallization. Though significant lowering of total GAGs was found to be associated with stone formers as compared with controls (23,24), the clinical role of GAGs on renal calculi formation remains controversial. With lupeol supplementation, the level of GAGs was found to be further lowered (Group IV), which may be attributed to the decreased entry of GAGs from the sites along the urinary tract due to amelioration of tubular injury.
Most of the urinary enzymes originate specifically from various portions and cellular components of the nephron (25). Increased oxalate content in the tissues cause damage to proximal tubular epithelium which is generally associated with shedding of the brush border membrane, thereby facilitating crystal retention (26). Hence, the measure of various urinary enzymes could be directly related to 
